Biotechnology News

Oxford, UK, September 16, 2026 – Theolytics, a clinical-stage biotechnology company developing next-generation oncolytic immunotherapies, today announced that members of its senior leadership team...

LVOne is the only stroke diagnostic in-vitro-diagnosis test device to earn CE Mark Certification

CAMBRIDGE, Royaume-Uni, 16 sept. 2026 (GLOBE NEWSWIRE) -- UpFront Diagnostics annonce l’obtention du marquage CE pour LVOne, présenté comme le premier test sanguin rapide au monde permettant de...

CAMBRIDGE, Vereinigtes Königreich, Sept. 16, 2026 (GLOBE NEWSWIRE) -- UpFront Diagnostics hat die CE-Zulassung für LVOne bekanntgegeben – den weltweit ersten Blut-Schnelltest zur Diagnose eines...

PARIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive non-viral vectorized gene therapies with...

TME Pharma updates shareholders on final NOX-A12 license talks, capital discipline, minimal dilution, and capturing positive biotech market momentum.

TME Pharma informe ses actionnaires des négociations finales pour NOX-A12, de sa rigueur financière, de la faible dilution et du marché biotech.

TOKYO and CAMBRIDGE, Mass., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB), announced today that “LEQEMBI® Pen”, the subcutaneous (SC) formulation of the...

HIGH POINT, N.C., Sept. 15, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential...

Lisa Pitt, Pharm.D., M.S.J. appointed Senior Vice President, Regulatory Affairs Shiguang Liu, M.D., Ph.D. appointed Vice President, Clinical Development REDWOOD CITY, Calif., Sept. 15, 2026 (GLOBE...